Jian Fang, Peng Yang, Bian Maohong
Department of Blood Transfusion, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Transfus Med Hemother. 2022 Mar 28;49(5):298-305. doi: 10.1159/000522102. eCollection 2022 Sep.
Erythrocyte transfusion is the most common therapeutic procedure in hospitalized patients. Adding standard preservatives to red blood cells allows them to be stored for up to 42 days. However, whether storage has an effect on the erythrocyte transcriptome has not been well-studied.
This study was designed to explore the change of key risk microRNA (miRNAs) in stored erythrocytes.
We reanalyzed differentially expressed genes in the gene expression dataset GSE114990 and predicted their target genes, followed by experimental Gene Ontology (GO) analysis and (Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. Furthermore, the PPI network of target genes was constructed by the STRING database, and the module analysis was carried out.
We found two differential miRNAs, which were hsa-miR-1245a and hsa-miR-381. Enrichment analysis of GO and KEGG pathways confirmed that these target genes were significantly enriched in organ and system development, anchoring junction, transcription factor binding, and pathways of cancer.
The results suggest that the miRNAs hsa-miR-381 and hsa-miR-1245a may serve as biomarkers for storage products of erythrocytes.
红细胞输血是住院患者最常见的治疗手段。向红细胞中添加标准防腐剂可使其保存长达42天。然而,储存对红细胞转录组是否有影响尚未得到充分研究。
本研究旨在探索储存红细胞中关键风险微小RNA(miRNA)的变化。
我们重新分析了基因表达数据集GSE114990中差异表达的基因,并预测了它们的靶基因,随后进行了实验性基因本体(GO)分析和京都基因与基因组百科全书(KEGG)通路分析。此外,通过STRING数据库构建了靶基因的蛋白质-蛋白质相互作用(PPI)网络,并进行了模块分析。
我们发现了两种差异miRNA,即hsa-miR-1245a和hsa-miR-381。GO和KEGG通路的富集分析证实,这些靶基因在器官和系统发育、锚定连接、转录因子结合以及癌症通路中显著富集。
结果表明,miRNA hsa-miR-381和hsa-miR-1245a可能作为红细胞储存产物的生物标志物。